inferior outcomes seen in elderly patients with hl
Published 3 years ago • 43 plays • Length 1:38Download video MP4
Download video MP3
Similar videos
-
2:18
treating patients with advanced-stage hl in the frontline and relapsed settings in 2024
-
0:53
ukall60 : identifying the standard of care for elderly patients with all
-
3:03
outcomes following venetoclax monotherapy in patients with r/r wm in the real-world setting
-
2:22
haplo-sct for older patients with aml/hr-mds: should age be a barrier to transplantation?
-
3:08
welcome to the video journal of hematology & hematological oncology 🎥🩸
-
1:34
single-center study evaluating the outcomes of patients with aml who relapsed after allosct
-
9:25
mgus diagnosis: a step-by-step approach
-
2:47
using artificial intelligence to estimate overall mortality and non-relapse mortality after allosct
-
1:05
identifying residual lscs that may evade standard mrd monitoring & lead to relapse in aml
-
0:55
the significance of cr as an endpoint in frail patients with multiple myeloma
-
1:22
diagnostics and treatment outcomes from primary cbcl
-
1:54
outcomes of classic hl, relapsed within one year of diagnosis, in the era of novel agents
-
8:57
outcomes of sct in t-all and t-lbl
-
3:23
patient characteristics and outcomes of allosct for bpdcn
-
2:45
continuity of care for patients with hematological predispositions to aml
-
2:03
comprehensive geriatric assessments can aid in selecting treatment for elderly patients with cll
-
1:43
long-term outcomes of the ifcg regimen for firstline treatment of patients with ighv-mutated cll
-
1:35
outcomes of allosct following blinatumomab in children and young adults with r/r b-all
-
3:40
outcomes of all stratified by socioeconomic factors
-
2:11
novel approaches in hl
-
2:08
impact of bridging therapy on the outcomes of patients with r/r myeloma treated with ide-cel